MedTrace Logo

Functional Genetic Variants Affecting Tacrolimus Trough Levels and Side Effects in Chinese Renal Transplantation.

NCT03083769 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1502

Last updated 2019-11-20

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether functional genetic variants can affect tacrolimus dose corrected trough levels and associate with the side effects in Chinese renal transplant recipients.

Conditions

  • Transplantation

Sponsors & Collaborators

  • Third Affiliated Hospital, Sun Yat-Sen University

    collaborator OTHER

  • 181 Central Hospital of the Chinese PLA

    collaborator OTHER

  • Southern Medical University, China

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-01-01
Primary Completion
2019-07-30
Completion
2019-08-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03083769 on ClinicalTrials.gov